Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.

Oncology reports - 1 Jan 2000

Harlozinska Antonina, Bar Julia K, Montenarh Mathias, Kartarius Sabine

Abstract excerpt

The role of tumor suppressor p21WAF1 expression in epithelial ovarian cancer has not been definitely explained and the clarification of mutual p53 and p21WAF1 relations considering proliferative activity seems to be very important for understanding of a functional link between p53 and cell-cycle control. Therefore the expression of p53 and p21WAF1 was assessed immunohistochemically in a series of 50 ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p21

Share to Cyclins

Share to Genes, Tumor Suppressor

Share to Immunoenzyme Techniques

Share to Proliferating Cell Nuclear Antigen

Source

Identifiers

PMID: 12375014

Genes

PCNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.PMID 12375014Read ↗

Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.Semantic proximity Read ↗

p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.Semantic proximity Read ↗

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.Semantic proximity Read ↗

p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.Semantic proximity Read ↗

P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.Semantic proximity Read ↗

p21WAF1 mutations and human malignancies.Semantic proximity Read ↗

p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations.Semantic proximity Read ↗

p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.Semantic proximity Read ↗

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.Semantic proximity Read ↗

Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.Semantic proximity Read ↗

p21 expression predicts outcome in p53-null ovarian carcinoma.Semantic proximity Read ↗

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.